Haima Therapeutics is a preclinical stage biotechnology company specializing in platelet-inspired therapies for the treatment of bleeding and blood-related ailments. Their innovative technology, SynthoPlate, is a nanoparticle-based hemostatic solution ...
Year Founded
2016
